"Androgenetic Alopecia-201 Topical – This ongoing Phase 2 open-label clinical trial is evaluating the safety and efficacy of ATI-502, a topical JAK1/3 inhibitor, on the regrowth of hair in 31 patients with androgenetic alopecia (Androgenetic Alopecia), also known as male/female pattern hair loss. 6-month data are expected in the...